DITTA is the global voice for diagnostic imaging, radiation therapy, healthcare IT, electromedical and radiopharmaceutical manufacturers to better communicate, coordinate and collaborate on matters of common interest between participating associations and member companies. DITTA enables participating associations and their member companies to work more effectively with international policymakers, organizations, professional associations and stakeholders. Learn more.

Our manufacturers' devices provide lifesaving information to clinicians.
DITTA's members represent the world’s medical imaging devices manufacturers.
DITTA unites the global medical imaging manufacturer community.


IMDRF 12-14 September, Florianopolis, Brazil

DITTA participated in the 10th IMDRF Conference in Florianopolis.

DITTA contributed to IMDRF:

  • Organising a Workshop on International Standards on Monday 12 September
  • Delivering the Industry views during the Stakeholder Forum. Click here to access presentation

Standards are everywhere and rightfully so!

Agenda is attached here.

Presentations can be accessed from the links below.

IMDRF 8-10 March 2016, Brasilia, Brazil

DITTA participated in the 9th IMDRF Conference in Brasilia.

DITTA contributed to IMDRF with the following:

  • Organising a Workshop on Medical Software on Monday 7 March
  • Delivering the Industry views during the Stakeholder Forum. Click here to access presentation

DITTA Workshop on Medical Software

How medical device regulations apply to medical software?

Agenda is attached here.

Presentations can be accessed from the links below.

Bakul PatelIMDRF SaMD Work Item: Overview on achievements and priorities 2016

Leandro Rodrigues Pereira

Eric Hansson

Bakul Patel – US status on medical software and update on Digital health

Patrick Hope

Peter Linders

Marcelo Antunes





World Cancer Day 2016: DITTA Raises Importance of Technologies

BRUSSELS – 4 February 2016 – Today is World Cancer Day 2016 and DITTA is taking this opportunity to raise awareness about the new and efficient clinical processes that medical technologies are enabling for the benefit of citizens and cancer patients across the globe in the collective fight against cancer.

Product and services delivered by DITTA industries provide innovative, advanced and effective solutions across the entire care cycle for the prevention, screening, early diagnosis, treatment, palliative care and monitoring of various cancers.

Over recent decades, the medical imaging industry has been instrumental in constantly innovating and developing advances in non-invasive technologies providing key tools that enable early prevention and screening and support early detection and diagnosis, which in turn impact on clinical outcomes and contribute to saving lives. The role of medical imaging in driving precision medicine, targeting the right patient with the right therapy at the right time, is also of paramount importance. Health ICT provides an infrastructure and other applications supporting the complete care cycle, allowing for more efficient clinical workflow and offering decision support tools to facilitate the work of multidisciplinary care teams. Finally, advances in radiotherapy now enable clinicians to cure localized disease, palliate symptoms, and control disease in incurable cancers, thereby contributing to improved patient outcomes and minimizing side effects in a cost-effective way. In an era of personalized medicine, radiotherapy beams may be shaped and modulated to conform to the exact shape of tumors, thereby optimizing the delivery of the prescribed dose to each part of the tumor while sparing normal tissues.

Nicole Denjoy, DITTA Vice Chair, says: “Considering that the campaign focus this year is ‘We can. I can.’, DITTA strongly supports the need for everyone to access effective, qualitative and affordable cancer care, benefiting from promising innovative technologies. DITTA is convinced that efforts to advance cancer research, diagnosis and targeted therapy should be increased, and has been striving to shape policy changes necessary to accelerate increased survival rates and improvements in cancer patient outcomes.” Nicole Denjoy added “More than 40% of cancer deaths could be prevented by using medical technologies smartly. Early and accurate diagnosis of cancer is essential in delivering better outcomes for patients. It is vital that patients have timely and affordable access to appropriate diagnostic tests, screening, and treatment technologies”.

For more information, contact:


Nicole Denjoy  

DITTA Vice-Chair

Tel: +32 (0)2 706 8961


Kathryn Sheridan

COCIR Communications Advisor

Tel: +32 (0)496 116198


See all News
  • Join Us

    For more information about joining DITTA click here

  • Update from DITTA

    Follow us on Twitter
    Read More